Virginia A. Triant

6.0k total citations · 1 hit paper
76 papers, 4.2k citations indexed

About

Virginia A. Triant is a scholar working on Emergency Medicine, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Virginia A. Triant has authored 76 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Emergency Medicine, 37 papers in Infectious Diseases and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Virginia A. Triant's work include HIV-related health complications and treatments (54 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (14 papers). Virginia A. Triant is often cited by papers focused on HIV-related health complications and treatments (54 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (14 papers). Virginia A. Triant collaborates with scholars based in United States, Botswana and Vietnam. Virginia A. Triant's co-authors include Steven Grinspoon, Hang Lee, Colleen Hadigan, James B. Meigs, Susan Regan, Todd T. Brown, Felicia C. Chow, Steven K. Feske, Markella V. Zanni and Ralph B. D’Agostino and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Virginia A. Triant

72 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease

2007 1.2k citations Virginia A. Triant, Steven Grinspoon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virginia A. Triant United States	28	3.3k	1.9k	1.3k	726	684	76	4.2k
Rebecca Scherzer United States	38	2.7k 0.8×	1.9k 1.0×	1.3k 1.0×	1.0k 1.4×	445 0.7×	177	4.9k
Nina Friis‐Møller Denmark	29	4.5k 1.4×	3.7k 2.0×	2.2k 1.7×	1.1k 1.6×	776 1.1×	57	5.9k
Jacqueline Neuhaus United States	24	2.8k 0.9×	2.2k 1.2×	1.9k 1.5×	981 1.4×	318 0.5×	38	4.2k
P. Mercié France	31	1.2k 0.4×	1.4k 0.7×	889 0.7×	619 0.9×	225 0.3×	122	2.9k
Chris T. Longenecker United States	25	1.8k 0.5×	934 0.5×	482 0.4×	648 0.9×	519 0.8×	136	2.8k
Nicholas I. Paton United Kingdom	18	1.7k 0.5×	1.4k 0.8×	1.4k 1.1×	493 0.7×	184 0.3×	39	2.7k
Fabrice Bonnet France	38	1.4k 0.4×	2.1k 1.1×	1.1k 0.9×	1.5k 2.1×	277 0.4×	173	4.4k
Lene Ryom Denmark	26	1.8k 0.5×	1.8k 1.0×	791 0.6×	855 1.2×	259 0.4×	74	2.9k
Federica Carli Italy	21	1.6k 0.5×	1.1k 0.6×	597 0.5×	644 0.9×	114 0.2×	42	2.2k
Matthew J. Feinstein United States	22	1.1k 0.3×	538 0.3×	304 0.2×	349 0.5×	474 0.7×	101	2.1k

Countries citing papers authored by Virginia A. Triant

Since Specialization

Citations

This map shows the geographic impact of Virginia A. Triant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia A. Triant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia A. Triant more than expected).

Fields of papers citing papers by Virginia A. Triant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia A. Triant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia A. Triant. The network helps show where Virginia A. Triant may publish in the future.

Co-authorship network of co-authors of Virginia A. Triant

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia A. Triant. A scholar is included among the top collaborators of Virginia A. Triant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia A. Triant. Virginia A. Triant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grinspoon, Steven, Markella V. Zanni, Virginia A. Triant, et al.. (2025). Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE. The Lancet HIV. 12(2). e118–e129. 9 indexed citations

Grinspoon, Steven, Estebán Martínez, Carl J. Fichtenbaum, et al.. (2025). Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2. Clinical Infectious Diseases. 82(2). e248–e257.

Azhir, Alaleh, Ingrid V. Bassett, Douglas S. Bell, et al.. (2024). Precision phenotyping for curating research cohorts of patients with unexplained post-acute sequelae of COVID-19. Med. 6(3). 100532–100532. 2 indexed citations

Triant, Virginia A., Asya Lyass, Leo B. Hurley, et al.. (2024). Cardiovascular Risk Estimation Is Suboptimal in People With HIV. Journal of the American Heart Association. 13(10). e029228–e029228. 11 indexed citations

Huck, Daniel, Brittany Weber, Sanjay Divakaran, et al.. (2023). Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy. Journal of the American Heart Association. 12(22). e029541–e029541. 6 indexed citations

Kiplagat, Jepchirchir, Dan N. Tran, Tristan Barber, et al.. (2022). How health systems can adapt to a population ageing with HIV and comorbid disease. The Lancet HIV. 9(4). e281–e292. 41 indexed citations

Robinson, Lacey B., Xiaoqing Fu, Ingrid V. Bassett, et al.. (2020). COVID-19 severity in hospitalized patients with asthma: A matched cohort study. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 497–500. 20 indexed citations

Chow, Felicia C., Asya Lyass, Taylor F. Mahoney, et al.. (2019). Baseline 10-Year Cardiovascular Risk Scores Predict Cognitive Function in Older Persons, and Particularly Women, Living With Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 71(12). 3079–3085. 9 indexed citations

Alvi, Raza M., Anne M. Neilan, Magid Awadalla, et al.. (2018). Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure. Journal of the American College of Cardiology. 72(5). 518–530. 73 indexed citations

10.

Chow, Felicia C., et al.. (2018). Stroke in HIV. Canadian Journal of Cardiology. 35(3). 280–287. 25 indexed citations

11.

Mosepele, Mosepele, Onkabetse Julia Molefe‐Baikai, Steven Grinspoon, & Virginia A. Triant. (2018). Benefits and Risks of Statin Therapy in the HIV-Infected Population. Current Infectious Disease Reports. 20(8). 20–20. 27 indexed citations

12.

Chang, Yuchiao, et al.. (2017). Non-Communicable Disease Preventive Screening by HIV Care Model. PLoS ONE. 12(1). e0169246–e0169246. 9 indexed citations

13.

Mosepele, Mosepele, et al.. (2017). Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa. PLoS ONE. 12(2). e0172897–e0172897. 36 indexed citations

14.

Feinstein, Matthew J., June‐Ho Kim, Jeffrey N. Martin, et al.. (2016). Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Research and Human Retroviruses. 33(1). 49–56. 34 indexed citations

15.

Raposeiras‐Roubín, Sergio & Virginia A. Triant. (2016). Cardiopatía isquémica en el VIH: profundizando en el conocimiento del riesgo cardiovascular. Revista Española de Cardiología. 69(12). 1204–1213. 6 indexed citations

16.

Raposeiras‐Roubín, Sergio & Virginia A. Triant. (2016). Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk. Revista Española de Cardiología (English Edition). 69(12). 1204–1213. 9 indexed citations

17.

Siedner, Mark J., June‐Ho Kim, Linda Hemphill, et al.. (2015). HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 30(4). 667–670. 23 indexed citations

18.

Triant, Virginia A.. (2014). Epidemiology of Coronary Heart Disease in HIV Patients. Reviews in Cardiovascular Medicine. 15. 7 indexed citations

19.

Suchindran, Sujit, Susan Regan, James B. Meigs, Steven Grinspoon, & Virginia A. Triant. (2014). Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients. Open Forum Infectious Diseases. 1(3). ofu076–ofu076. 28 indexed citations

20.

Longenecker, Chris T. & Virginia A. Triant. (2013). Initiation of antiretroviral therapy at high CD4 cell counts. Current Opinion in HIV and AIDS. 9(1). 54–62. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact